chr10-103089690-CTCCTCT-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP3BP3
The NM_001351169.2(NT5C2):c.1662_1667delAGAGGA(p.Glu555_Glu556del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,607,820 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. E554E) has been classified as Likely benign.
Frequency
Consequence
NM_001351169.2 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- hypomagnesemia, seizures, and intellectual disability 1Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)
- renal hypomagnesemia 6Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial primary hypomagnesemia with normocalciuria and normocalcemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NT5C2 | NM_001351169.2 | c.1662_1667delAGAGGA | p.Glu555_Glu556del | disruptive_inframe_deletion | Exon 19 of 19 | ENST00000404739.8 | NP_001338098.1 | |
CNNM2 | NM_017649.5 | c.*12513_*12518delCTCTTC | 3_prime_UTR_variant | Exon 8 of 8 | ENST00000369878.9 | NP_060119.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NT5C2 | ENST00000404739.8 | c.1662_1667delAGAGGA | p.Glu555_Glu556del | disruptive_inframe_deletion | Exon 19 of 19 | 1 | NM_001351169.2 | ENSP00000383960.3 | ||
CNNM2 | ENST00000369878.9 | c.*12513_*12518delCTCTTC | 3_prime_UTR_variant | Exon 8 of 8 | 1 | NM_017649.5 | ENSP00000358894.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152126Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000813 AC: 2AN: 246030 AF XY: 0.00000753 show subpopulations
GnomAD4 exome AF: 0.0000131 AC: 19AN: 1455694Hom.: 0 AF XY: 0.0000152 AC XY: 11AN XY: 723828 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74292 show subpopulations
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 45 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 541768). This variant has not been reported in the literature in individuals affected with NT5C2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Glu560*) in the NT5C2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2 amino acid(s) of the NT5C2 protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at